⚕️
Medikal Tanı ve Test Sektörü Hisseleri
Medikal Tanı ve Test Sektörü altında 222 Hisse Senedi
Medikal Tanı ve Test sektöründe faaliyet gösteren ABD şirketlerinin hisse senetleri. Gerçek zamanlı fiyatlar, finansal analizler ve detaylı şirket bilgileri.
100
Toplam Hisse
$20.8B
Toplam Piyasa Değeri
Medikal Tanı ve Test Sektörü Hisseleri
Sayfa 2/3 (Toplam: 222)
| SEMBOL | ŞİRKET | PİYASA DEĞERİ | FİYAT | DEĞİŞİM |
|---|---|---|---|---|
| PACB | Pacific Biosciences of California, Inc. | $695.90M | $2.31 | 3.56% |
| NUTX | Nutex Health, Inc. | $685.40M | $115.11 | 2.05% |
| CGEM | Cullinan Oncology, Inc. | $671.69M | $11.37 | 3.15% |
| CBLL | CeriBell, Inc. | $629.51M | $16.97 | 0.35% |
| PROK | ProKidney Corp. | $624.73M | $2.22 | 4.72% |
| EBS | Emergent BioSolutions Inc. | $602.90M | $11.17 | 1.09% |
| LAB | Standard BioTools Inc. | $576.85M | $1.50 | 4.90% |
| RGLS | Regulus Therapeutics Inc. | $564.95M | $8.16 | 0.00% |
| AVNS | Avanos Medical, Inc. | $544.88M | $11.74 | 0.84% |
| ANNX | Annexon, Inc. | $538.18M | $4.50 | 4.17% |
| BVS | Bioventus Inc. | $507.98M | $7.59 | 0.78% |
| DNA | Ginkgo Bioworks Holdings, Inc. | $507.12M | $9.28 | 1.87% |
| ABSI | Absci Corporation | $478.18M | $3.18 | 2.91% |
| EHAB | Enhabit, Inc. | $452.81M | $8.94 | 1.00% |
| MLAB | Mesa Laboratories, Inc. | $442.89M | $80.20 | 0.19% |
| SIGA | SIGA Technologies, Inc. | $433.96M | $6.06 | 0.33% |
| ANRO | Alto Neuroscience, Inc. | $430.27M | $13.85 | 2.52% |
| AURA | Aura Biosciences, Inc. | $419.11M | $6.60 | 3.45% |
| PRTC | PureTech Health plc | $403.61M | $16.70 | 4.38% |
| LCTX | Lineage Cell Therapeutics, Inc. | $401.41M | $1.75 | 2.05% |
| TECX | Tectonic Therapeutic, Inc. | $401.28M | $21.44 | 0.23% |
| MG | Mistras Group, Inc. | $378.26M | $11.99 | 1.10% |
| GALT | Galectin Therapeutics Inc. | $368.93M | $5.73 | 0.52% |
| BIOA | BioAge Labs, Inc. | $340.26M | $9.49 | 1.50% |
| QTRX | Quanterix Corporation | $339.12M | $7.26 | 1.63% |
| CERS | Cerus Corporation | $337.85M | $1.76 | 0.00% |
| SMLR | Semler Scientific, Inc. | $329.27M | $21.72 | 5.03% |
| PYXS | Pyxis Oncology, Inc. | $323.08M | $5.19 | 1.70% |
| TOI | The Oncology Institute, Inc. | $310.39M | $3.15 | 1.12% |
| NEO | NeoGenomics, Inc. | $309.11M | $12.10 | 0.25% |
| NAUT | Nautilus Biotechnology, Inc. | $284.19M | $2.25 | 0.88% |
| IMRX | Immuneering Corporation | $278.08M | $7.66 | 2.00% |
| QSI | Quantum-Si incorporated | $276.71M | $1.42 | 4.81% |
| SENS | Senseonics Holdings, Inc. | $252.46M | $6.18 | 2.32% |
| CAPR | Capricor Therapeutics, Inc. | $244.59M | $5.35 | 3.08% |
| MASS | 908 Devices Inc. | $229.82M | $6.35 | 0.94% |
| GNLX | Genelux Corporation | $211.57M | $5.56 | 0.54% |
| OABI | OmniAb, Inc. | $194.80M | $1.81 | 2.69% |
| RPID | Rapid Micro Biosystems, Inc. | $185.79M | $4.19 | 1.21% |
| ARCT | Arcturus Therapeutics Holdings Inc. | $184.19M | $6.79 | 0.15% |
| OSUR | OraSure Technologies, Inc. | $176.82M | $2.38 | 0.00% |
| CATX | Perspective Therapeutics, Inc. | $174.66M | $2.35 | 5.38% |
| MCRB | Seres Therapeutics, Inc. | $157.86M | $17.99 | 6.64% |
| SAVA | Cassava Sciences, Inc. | $157.53M | $3.26 | 3.81% |
| AGEN | Agenus Inc. | $154.59M | $4.56 | 0.22% |
| ANIX | Anixa Biosciences, Inc. | $151.07M | $4.59 | 1.08% |
| IMMX | Immix Biopharma, Inc. | $142.69M | $4.25 | 1.16% |
| ALEC | Alector, Inc. | $133.79M | $1.33 | 1.11% |
| OVID | Ovid Therapeutics Inc. | $126.59M | $1.78 | 9.20% |
| SERA | Sera Prognostics, Inc. | $125.30M | $3.33 | 0.30% |
| ARAY | Accuray Incorporated | $122.37M | $1.08 | 3.85% |
| ABOS | Acumen Pharmaceuticals, Inc. | $113.88M | $1.88 | 3.59% |
| INO | Inovio Pharmaceuticals, Inc. | $110.40M | $2.06 | 5.10% |
| COYA | Coya Therapeutics, Inc. | $108.17M | $6.51 | 2.04% |
| LUCD | Lucid Diagnostics Inc. | $107.87M | $1.06 | 0.93% |
| SEER | Seer, Inc. | $107.12M | $1.92 | 1.54% |
| ICAD | iCAD, Inc. | $106.31M | $3.87 | 3.75% |
| DCGO | DocGo Inc. | $100.74M | $1.03 | 0.96% |
| STTK | Shattuck Labs, Inc. | $100.60M | $2.10 | 1.41% |
| ATOS | Atossa Therapeutics, Inc. | $100.43M | $0.78 | 0.29% |
| MGNX | MacroGenics, Inc. | $96.79M | $1.53 | 3.38% |
| OCX | OncoCyte Corporation | $91.52M | $3.20 | 17.22% |
| OM | Outset Medical, Inc. | $82.68M | $4.55 | 2.59% |
| HYPR | Hyperfine, Inc. | $81.53M | $1.07 | 2.88% |
| STRO | Sutro Biopharma, Inc. | $78.26M | $0.92 | 3.73% |
| IGMS | IGM Biosciences, Inc. | $77.50M | $1.27 | 0.00% |
| OPGN | OpGen, Inc. | $75.53M | $7.50 | 17.19% |
| IPA | ImmunoPrecise Antibodies Ltd. | $74.77M | $1.62 | 2.53% |
| ALXO | ALX Oncology Holdings Inc. | $74.28M | $1.37 | 0.72% |
| LUNG | Pulmonx Corporation | $66.82M | $1.62 | 0.61% |
| AKYA | Akoya Biosciences, Inc. | $64.44M | $1.29 | 5.15% |
| TCRX | TScan Therapeutics, Inc. | $63.00M | $1.11 | 0.00% |
| BDSX | Biodesix, Inc. | $61.11M | $8.28 | 5.21% |
| SNTI | Senti Biosciences, Inc. | $58.62M | $2.23 | 5.69% |
| BCAB | BioAtla, Inc. | $53.15M | $0.90 | 6.27% |
| CVM | CEL-SCI Corporation | $52.67M | $7.67 | 2.06% |
| CUE | Cue Biopharma, Inc. | $49.60M | $0.63 | 0.67% |
| CELU | Celularity Inc. | $47.75M | $1.99 | 0.25% |
| INMB | INmune Bio, Inc. | $46.26M | $1.74 | 5.45% |
| MAIA | MAIA Biotechnology, Inc. | $43.70M | $1.18 | 11.32% |
| RNTX | Rein Therapeutics Inc. | $41.27M | $1.57 | 1.95% |
| LTRN | Lantern Pharma Inc. | $40.49M | $3.62 | 4.74% |
| PDSB | PDS Biotechnology Corporation | $37.76M | $0.77 | 5.20% |
| PRPO | Precipio, Inc. | $37.46M | $24.38 | 0.47% |
| CCEL | Cryo-Cell International, Inc. | $34.63M | $4.30 | 5.91% |
| RENB | Renovaro Biosciences Inc. | $32.92M | $1.42 | 0.00% |
| NOTV | Inotiv, Inc. | $31.80M | $0.93 | 6.32% |
| JSPR | Jasper Therapeutics, Inc. | $29.90M | $1.84 | 5.44% |
| FEMY | Femasys Inc. | $29.74M | $1.01 | 1.97% |
| BOLD | Boundless Bio, Inc. | $26.19M | $1.17 | 5.41% |
| BEAT | HeartBeam, Inc. | $25.78M | $0.75 | 24.23% |
| NNVC | NanoViricides, Inc. | $21.80M | $1.22 | 3.17% |
| ELEV | Elevation Oncology, Inc. | $21.63M | $0.36 | 2.12% |
| IBIO | iBio, Inc. | $20.33M | $1.23 | 2.50% |
| SYBX | Synlogic, Inc. | $17.08M | $1.46 | 11.52% |
| CTXR | Citius Pharmaceuticals, Inc. | $16.09M | $1.44 | 2.86% |
| AYTU | Aytu BioPharma, Inc. | $15.60M | $2.19 | 4.29% |
| LGVN | Longeveron Inc. | $14.17M | $0.66 | 2.50% |
| PHIO | Phio Pharmaceuticals Corp. | $13.67M | $1.27 | 3.25% |
| CODX | Co-Diagnostics, Inc. | $12.55M | $0.37 | 0.72% |